share_log

HOOKIPA Pharma | DEFA14A: Others

SEC announcement ·  Apr 27 04:45
Summary by Futu AI
HOOKIPA Pharma Inc. has filed a DEFA14A form with the United States Securities and Exchange Commission (SEC), indicating the submission of additional proxy soliciting materials. The filing, which is part of the regulatory requirements under Section 14(a) of the Securities Exchange Act of 1934, does not require a filing fee. This submission by HOOKIPA Pharma is a definitive additional material, suggesting that it is likely a follow-up to a previously filed proxy statement. The materials are intended for use in connection with a shareholder meeting or vote, although the specific resolutions or proposals are not detailed in the announcement.
HOOKIPA Pharma Inc. has filed a DEFA14A form with the United States Securities and Exchange Commission (SEC), indicating the submission of additional proxy soliciting materials. The filing, which is part of the regulatory requirements under Section 14(a) of the Securities Exchange Act of 1934, does not require a filing fee. This submission by HOOKIPA Pharma is a definitive additional material, suggesting that it is likely a follow-up to a previously filed proxy statement. The materials are intended for use in connection with a shareholder meeting or vote, although the specific resolutions or proposals are not detailed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.